Douglas E. Love
CEO, President & DirectorMr. Douglas E. Love, also known as Doug, Esq., J.D., is Director of Sphinx Organization, Inc. Mr. Douglas E. Love, Esq., J.D, also known as Doug, has been the President, Director and Chief Executive Officer of Annexon Inc. since December 2014. He has extensive business and legal leadership experience in biotech. From 2008 to April 2013, he served as Head of Operations & Strategic Alliances at Elan Pharmaceuticals, Inc. From 2006 to 2008, he served as Head of Strategic Alliances and Business Development & Business Integration at Elan. Mr. Love led the Tysabri® multiple sclerosis franchise, helping to propel it to annual sales, as well as Elan’s Alzheimer’s Immunotherapy Program, which was licensed to Johnson & Johnson milestones and royalties. He also led Elan’s global Commercial, Medical Affairs ad Alliance Management groups. Mr. Love is a Corporate Attorney by training. Prior to joining Elan, Mr. Love served as an Associate at the law firm Orrick, Herrington & Sutcliffe and Corporate Counsel at Amgen, Inc. and as Section Corporate Counsel at Genentech Inc., where he led the BioOncology Healthcare Law Group and launched several blockbuster programs. Mr. Love holds a J.D. with great distinction from McGeorge School of Law, Sacramento, CA and a B.S. in business administration from the University of Southern California.
公司职务
- 公司名称Annexon, Inc.股票代码ANNX职务CEO, President & Director共事同僚
- JLJennifer LewExecutive VP, CFO & Corporate Secretary
- TYTed YednockExecutive VP, Chief Innovation Officer & Chairman of the Scientific Advisory Board
- DRDean R. ArtisChief Scientific Officer & Executive VP
- LALinda A. FitzpatrickChief Human Resources Officer
- JEJung E. ChoiIndependent Director
- WDWilliam D. WaddillInterim Lead Independent Director
- PHP. Hugh WillisonMember of Scientific Advisory Board
